TreeWAS – Variant ID: rs141863958

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z88.8 Personal history of allergy to other drugs, medicaments and biological substances	0.067	0.933	0.000
Z88 Personal history of allergy to drugs, medicaments and biologocal substances	0.065	0.935	0.000
Z88.5 Personal history of allergy to narcotic agent	0.064	0.936	0.000
Z88.6 Personal history of allergy to analgesic agent	0.060	0.940	0.000
Z88.3 Personal history of allergy to other anti-infective agents	0.059	0.941	0.000
Z88.1 Personal history of allergy to other antibiotic agents	0.057	0.943	0.000
Z88.4 Personal history of allergy to anaesthetic agent	0.047	0.953	0.000
Z88.9 Personal history of allergy to unspecified drugs, medicaments and biological substances	0.046	0.953	0.000
Z88.7 Personal history of allergy to serum and vaccine	0.043	0.957	0.000
Z88.2 Personal history of allergy to sulphonamides	0.023	0.976	0.000
D12 Benign neoplasm of colon, rectum, anus and anal canal	0.014	0.986	0.000
D12.6 Colon, unspecified	0.014	0.986	0.000
D12.9 Anus and anal canal	0.013	0.987	0.000
D12.8 Rectum	0.013	0.987	0.000
D12.3 Transverse colon	0.013	0.987	0.000
D12.0 Caecum	0.012	0.987	0.000
D12.2 Ascending colon	0.012	0.988	0.000
D12.4 Descending colon	0.012	0.988	0.000
D12.1 Appendix	0.010	0.989	0.000
D12.5 Sigmoid colon	0.010	0.990	0.000
H40.9 Glaucoma, unspecified	0.010	0.990	0.000
D12.7 Rectosigmoid junction	0.009	0.991	0.000
K83.8 Other specified diseases of biliary tract	0.009	0.991	0.000
K83 Other diseases of biliary tract	0.009	0.991	0.000
K83.1 Obstruction of bile duct	0.008	0.992	0.000
K83.0 Cholangitis	0.008	0.992	0.000
R10.3 Pain localised to other parts of lower abdomen	0.000	0.992	0.008
K86 Other diseases of pancreas	0.007	0.993	0.000
K83.9 Disease of biliary tract, unspecified	0.006	0.994	0.000
K83.5 Biliary cyst	0.006	0.994	0.000
K83.4 Spasm of sphincter of Oddi	0.006	0.994	0.000
K83.3 Fistula of bile duct	0.006	0.994	0.000
K83.2 Perforation of bile duct	0.006	0.994	0.000
K86.3 Pseudocyst of pancreas	0.006	0.994	0.000
K86.0 Alcohol-induced chronic pancreatitis	0.006	0.994	0.000
K80-K87 Disorders of gallbladder, biliary tract and pancreas	0.006	0.994	0.000
H40 Glaucoma	0.006	0.994	0.000
K86.8 Other specified diseases of pancreas	0.006	0.994	0.000
K80.0 Calculus of gallbladder with acute cholecystitis	0.006	0.994	0.000
K86.2 Cyst of pancreas	0.005	0.995	0.000
K86.1 Other chronic pancreatitis	0.005	0.995	0.000
K80 Cholelithiasis	0.005	0.995	0.000
H40.1 Primary open-angle glaucoma	0.005	0.995	0.000
K86.9 Disease of pancreas, unspecified	0.005	0.995	0.000
K80.8 Other cholelithiasis	0.005	0.995	0.000
S82.10 Fracture of upper end of tibia (closed)	0.005	0.995	0.000
D36.1 Peripheral nerves and autonomic nervous system	0.005	0.995	0.000
K80.4 Calculus of bile duct with cholecystitis	0.004	0.995	0.000
K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere	0.004	0.996	0.000
H40.8 Other glaucoma	0.004	0.996	0.000
H40.6 Glaucoma secondary to drugs	0.004	0.996	0.000
H40.5 Glaucoma secondary to other eye disorders	0.004	0.996	0.000
H40.4 Glaucoma secondary to eye inflammation	0.004	0.996	0.000
H40.3 Glaucoma secondary to eye trauma	0.004	0.996	0.000
S82.1 Fracture of upper end of tibia	0.004	0.996	0.000
D36 Benign neoplasm of other and unspecified sites	0.004	0.996	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.004	0.996	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.004	0.996	0.000
K80.3 Calculus of bile duct with cholangitis	0.004	0.996	0.000
K85 Acute pancreatitis	0.004	0.996	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.004	0.996	0.000
S82 Fracture of lower leg, including ankle	0.004	0.996	0.000
H40.2 Primary angle-closure glaucoma	0.004	0.996	0.000
D10-D36 Benign neoplasms	0.004	0.996	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.004	0.996	0.000
M47.96 Spondylosis, unspecified (Lumbar region)	0.000	0.996	0.004
H40.0 Glaucoma suspect	0.004	0.996	0.000
K82 Other diseases of gallbladder	0.004	0.996	0.000
S82.3 Fracture of lower end of tibia	0.004	0.996	0.000
D24 Benign neoplasm of breast	0.004	0.996	0.000
Y45.0 Opioids and related analgesics	0.004	0.996	0.000
Y52 Agents primarily affecting the cardiovascular system	0.004	0.996	0.000
S82.30 Fracture of lower end of tibia (closed)	0.003	0.996	0.000
M47.9 Spondylosis, unspecified	0.000	0.997	0.003
Y40 Systemic antibiotics	0.003	0.997	0.000
K87.1 Disorders of pancreas in diseases classified elsewhere	0.003	0.997	0.000
K87.0 Disorders of gallbladder and biliary tract in diseases classified elsewhere	0.003	0.997	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
S82.5 Fracture of medial malleolus	0.003	0.997	0.000
Y43 Primarily systemic agents	0.003	0.997	0.000
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.003	0.997	0.000
K80.1 Calculus of gallbladder with other cholecystitis	0.003	0.997	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
M47.92 Spondylosis, unspecified (Cervical region)	0.000	0.997	0.003
Y42.7 Androgens and anabolic congeners	0.003	0.997	0.000
D33 Benign neoplasm of brain and other parts of central nervous system	0.003	0.997	0.000
S82.11 Fracture of upper end of tibia (open)	0.003	0.997	0.000
S82.6 Fracture of lateral malleolus	0.003	0.997	0.000
D36.9 Benign neoplasm of unspecified site	0.003	0.997	0.000
D36.7 Other specified sites	0.003	0.997	0.000
D36.0 Lymph nodes	0.003	0.997	0.000
Y45.1 Salicylates	0.003	0.997	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.003	0.997	0.000
Y45.8 Other analgesics and antipyretics	0.003	0.997	0.000
Y45.5 4-Aminophenol derivatives	0.003	0.997	0.000
Y45.4 Antirheumatics	0.003	0.997	0.000
Y45.2 Propionic acid derivatives	0.003	0.997	0.000
Y40.8 Other systemic antibiotics	0.003	0.997	0.000
D23 Other benign neoplasms of skin	0.003	0.997	0.000
D21 Other benign neoplasms of connective and other soft tissue	0.003	0.997	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.003	0.997	0.000
K80.36 Calculus of bile duct with acute and chronic cholangitis without obstruction	0.003	0.997	0.000
Y59 Other and unspecified vaccines and biological substances	0.003	0.997	0.000
Y58 Bacterial vaccines	0.003	0.997	0.000
Y57 Other and unspecified drugs and medicaments	0.003	0.997	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.997	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.997	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.003	0.997	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.003	0.997	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y48 Anaesthetics and therapeutic gases	0.003	0.997	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.003	0.997	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
S82.50 Fracture of medial malleolus (closed)	0.003	0.997	0.000
D26 Other benign neoplasms of uterus	0.003	0.997	0.000
K85.8 Other acute pancreatitis	0.003	0.997	0.000
K85.3 Drug-induced acute pancreatitis	0.003	0.997	0.000
K85.2 Alcohol-induced acute pancreatitis	0.003	0.997	0.000
K85.0 Idiopathic acute pancreatitis	0.003	0.997	0.000
D28 Benign neoplasm of other and unspecified female genital organs	0.003	0.997	0.000
Y44 Agents primarily affecting blood constituents	0.003	0.997	0.000
M47.99 Spondylosis, unspecified (Site unspecified)	0.000	0.997	0.003
S82.4 Fracture of fibula alone	0.003	0.997	0.000
K82.9 Disease of gallbladder, unspecified	0.003	0.997	0.000
S82.0 Fracture of patella	0.003	0.997	0.000
D23.4 Skin of scalp and neck	0.003	0.997	0.000
S82.9 Fracture of lower leg, part unspecified	0.003	0.997	0.000
S82.7 Multiple fractures of lower leg	0.003	0.997	0.000
D11 Benign neoplasm of major salivary glands	0.003	0.997	0.000
S82.8 Fractures of other parts of lower leg	0.003	0.997	0.000
Y43.4 Immunosuppressive agents	0.003	0.997	0.000
Y42.9 Other and unspecified hormone antagonists	0.003	0.997	0.000
Y42.4 Oral contraceptives	0.003	0.997	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.003	0.997	0.000
Y42.2 Antithyroid drugs	0.003	0.997	0.000
Y42.1 Thyroid hormones and substitutes	0.003	0.997	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.003	0.997	0.000
D31 Benign neoplasm of eye and adnexa	0.003	0.997	0.000
D30 Benign neoplasm of urinary organs	0.003	0.997	0.000
D29 Benign neoplasm of male genital organs	0.003	0.997	0.000
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum	0.003	0.997	0.000
D19 Benign neoplasm of mesothelial tissue	0.003	0.997	0.000
D16 Benign neoplasm of bone and articular cartilage	0.003	0.997	0.000
D15 Benign neoplasm of other and unspecified intrathoracic organs	0.003	0.997	0.000
D14 Benign neoplasm of middle ear and respiratory system	0.003	0.997	0.000
M13.99 Arthritis, unspecified (Site unspecified)	0.003	0.997	0.000
D27 Benign neoplasm of ovary	0.003	0.997	0.000
D23.7 Skin of lower limb, including hip	0.003	0.997	0.000
K82.3 Fistula of gallbladder	0.003	0.997	0.000
K82.2 Perforation of gallbladder	0.003	0.997	0.000
K82.1 Hydrops of gallbladder	0.003	0.997	0.000
K82.0 Obstruction of gallbladder	0.003	0.997	0.000
K85.9 Acute pancreatitis, unspecified	0.003	0.997	0.000
Y42.5 Other oestrogens and progestogens	0.003	0.997	0.000
S82.31 Fracture of lower end of tibia (open)	0.003	0.997	0.000
D33.3 Cranial nerves	0.003	0.997	0.000
S82.2 Fracture of shaft of tibia	0.003	0.997	0.000
D32 Benign neoplasm of meninges	0.003	0.997	0.000
D18 Haemangioma and lymphangioma, any site	0.003	0.997	0.000
D10 Benign neoplasm of mouth and pharynx	0.003	0.997	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
Y52.7 Peripheral vasodilators	0.003	0.997	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.003	0.997	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
Y52.1 Calcium-channel blockers	0.003	0.997	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
K85.1 Biliary acute pancreatitis	0.003	0.997	0.000
Y40.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
D21.2 Connective and other soft tissue of lower limb, including hip	0.003	0.997	0.000
S82.60 Fracture of lateral malleolus (closed)	0.003	0.997	0.000
M47.98 Spondylosis, unspecified (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M47.95 Spondylosis, unspecified (Thoracolumbar region)	0.000	0.997	0.003
M47.94 Spondylosis, unspecified (Thoracic region)	0.000	0.997	0.003
M47.93 Spondylosis, unspecified (Cervicothoracic region)	0.000	0.997	0.003
M47.91 Spondylosis, unspecified (Occipito-atlanto-axial region)	0.000	0.997	0.003
M47.90 Spondylosis, unspecified (Multiple sites in spine)	0.000	0.997	0.003
Y40.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
Y40.6 Rifamycins	0.003	0.997	0.000
Y40.5 Aminoglycosides	0.003	0.997	0.000
Y40.4 Tetracyclines	0.003	0.997	0.000
Y40.3 Macrolides	0.003	0.997	0.000
Y40.2 Chloramphenicol group	0.003	0.997	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.003	0.997	0.000
M20.1 Hallux valgus (acquired)	0.003	0.997	0.000
T84.0 Mechanical complication of internal joint prosthesis	0.003	0.997	0.000
M47.8 Other spondylosis	0.000	0.997	0.003
S82.51 Fracture of medial malleolus (open)	0.003	0.997	0.000
D23.0 Skin of lip	0.003	0.997	0.000
Y43.9 Primarily systemic agent, unspecified	0.003	0.997	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.003	0.997	0.000
Y43.6 Enzymes, not elsewhere classified	0.003	0.997	0.000
Y43.5 Acidifying and alkalising agents	0.003	0.997	0.000
Y43.2 Antineoplastic natural products	0.003	0.997	0.000
Y43.1 Antineoplastic antimetabolites	0.003	0.997	0.000
Y43.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
M47.82 Other spondylosis (Cervical region)	0.000	0.997	0.003
D37.4 Colon	0.003	0.997	0.000
H40-H42 Glaucoma	0.003	0.997	0.000
K82.8 Other specified diseases of gallbladder	0.003	0.997	0.000
D13 Benign neoplasm of other and ill-defined parts of digestive system	0.003	0.997	0.000
Y43.3 Other antineoplastic drugs	0.003	0.997	0.000
Y40.0 Penicillins	0.002	0.997	0.000
D26.1 Corpus uteri	0.002	0.997	0.000
D33.9 Central nervous system, unspecified	0.002	0.997	0.000
D33.7 Other specified parts of central nervous system	0.002	0.997	0.000
D33.4 Spinal cord	0.002	0.997	0.000
D33.2 Brain, unspecified	0.002	0.997	0.000
D33.1 Brain, infratentorial	0.002	0.997	0.000
D33.0 Brain, supratentorial	0.002	0.997	0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.003	0.997	0.000
M47.87 Other spondylosis (Lumbosacral region)	0.000	0.997	0.003
M47.97 Spondylosis, unspecified (Lumbosacral region)	0.000	0.997	0.002
S82.61 Fracture of lateral malleolus (open)	0.002	0.997	0.000
D28.0 Vulva	0.002	0.997	0.000
D37.5 Rectum	0.003	0.997	0.000
D21.9 Connective and other soft tissue, unspecified	0.002	0.997	0.000
D21.6 Connective and other soft tissue of trunk, unspecified	0.002	0.997	0.000
D21.5 Connective and other soft tissue of pelvis	0.002	0.997	0.000
D21.4 Connective and other soft tissue of abdomen	0.002	0.997	0.000
D21.3 Connective and other soft tissue of thorax	0.002	0.997	0.000
D21.0 Connective and other soft tissue of head, face and neck	0.002	0.997	0.000
D23.9 Skin, unspecified	0.002	0.997	0.000
D23.2 Skin of ear and external auricular canal	0.002	0.997	0.000
D22 Melanocytic naevi	0.003	0.997	0.000
M47 Spondylosis	0.000	0.997	0.002
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.997	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.997	0.000
Y41.5 Antiviral drugs	0.002	0.997	0.000
Y41.4 Anthelminthics	0.002	0.997	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.997	0.000
Y41.1 Antimycobacterial drugs	0.002	0.997	0.000
Y41.0 Sulphonamides	0.002	0.997	0.000
Y46.8 Antispasticity drugs	0.002	0.997	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.997	0.000
Y46.6 Other and unspecified antiepileptics	0.002	0.997	0.000
Y46.5 Valproic acid	0.002	0.997	0.000
Y46.4 Iminostilbenes	0.002	0.997	0.000
Y46.3 Deoxybarbiturates	0.002	0.997	0.000
Y46.2 Hydantoin derivatives	0.002	0.997	0.000
Y46.1 Oxazolidinediones	0.002	0.997	0.000
Y46.0 Succinimides	0.002	0.997	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.997	0.000
Y47.4 Bromine compounds	0.002	0.997	0.000
Y47.3 Paraldehyde	0.002	0.997	0.000
Y47.2 Chloral derivatives	0.002	0.997	0.000
Y47.1 Benzodiazepines	0.002	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.997	0.000
Y48.5 Therapeutic gases	0.002	0.997	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.997	0.000
Y48.3 Local anaesthetics	0.002	0.997	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.997	0.000
Y48.1 Parenteral anaesthetics	0.002	0.997	0.000
Y48.0 Inhaled anaesthetics	0.002	0.997	0.000
Y49.9 Psychotropic drug, unspecified	0.002	0.997	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.997	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.997	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.997	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.997	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.997	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.997	0.000
Y49.2 Other and unspecified antidepressants	0.002	0.997	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.997	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.997	0.000
Y50.9 Central nervous system stimulant, unspecified	0.002	0.997	0.000
Y50.8 Other central nervous system stimulants	0.002	0.997	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.997	0.000
Y50.1 Opioid receptor antagonists	0.002	0.997	0.000
Y50.0 Analeptics	0.002	0.997	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.997	0.000
Y53.7 Emetics	0.002	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.997	0.000
Y53.5 Digestants	0.002	0.997	0.000
Y53.4 Other laxatives	0.002	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.997	0.000
Y53.2 Stimulant laxatives	0.002	0.997	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.997	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.997	0.000
Y54.8 Agents affecting uric acid metabolism	0.002	0.997	0.000
Y54.7 Agents affecting calcification	0.002	0.997	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.997	0.000
Y54.5 Other diuretics	0.002	0.997	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.997	0.000
Y54.3 Benzothiadiazine derivatives	0.002	0.997	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.997	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.997	0.000
Y54.0 Mineralocorticoids	0.002	0.997	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.997	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.997	0.000
Y55.5 Anticommon cold drugs	0.002	0.997	0.000
Y55.4 Expectorants	0.002	0.997	0.000
Y55.3 Antitussives	0.002	0.997	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.997	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.997	0.000
Y55.0 Oxytocic drugs	0.002	0.997	0.000
Y56.9 Topical agent, unspecified	0.002	0.997	0.000
Y56.8 Other topical agents	0.002	0.997	0.000
Y56.7 Dental drugs, topically applied	0.002	0.997	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.997	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.997	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.997	0.000
Y56.2 Local astringents and local detergents	0.002	0.997	0.000
Y56.1 Antipruritics	0.002	0.997	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.997	0.000
Y57.9 Drug or medicament, unspecified	0.002	0.997	0.000
Y57.8 Other drugs and medicaments	0.002	0.997	0.000
Y57.7 Vitamins, not elsewhere classified	0.002	0.997	0.000
Y57.6 Other diagnostic agents	0.002	0.997	0.000
Y57.5 X-ray contrast media	0.002	0.997	0.000
Y57.4 Pharmaceutical excipients	0.002	0.997	0.000
Y57.3 Alcohol deterrents	0.002	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.997	0.000
Y57.1 Lipotropic drugs	0.002	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.997	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.997	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.997	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.997	0.000
Y58.5 Diphtheria vaccine	0.002	0.997	0.000
Y58.4 Tetanus vaccine	0.002	0.997	0.000
Y58.3 Plague vaccine	0.002	0.997	0.000
Y58.2 Cholera vaccine	0.002	0.997	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.997	0.000
Y58.0 BCG vaccine	0.002	0.997	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.997	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.997	0.000
Y59.3 Immunoglobulin	0.002	0.997	0.000
Y59.2 Protozoal vaccines	0.002	0.997	0.000
Y59.1 Rickettsial vaccines	0.002	0.997	0.000
Y59.0 Viral vaccines	0.002	0.997	0.000
W00-W19 Falls	0.003	0.997	0.000
D26.9 Uterus, unspecified	0.002	0.997	0.000
D26.7 Other parts of uterus	0.002	0.997	0.000
D26.0 Cervix uteri	0.002	0.997	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.997	0.000
Y44.7 Plasma substitutes	0.002	0.997	0.000
Y44.6 Natural blood and blood products	0.002	0.997	0.000
Y44.5 Thrombolytic drugs	0.002	0.997	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.997	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.997	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.997	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.997	0.000
S82.40 Fracture of fibula alone (closed)	0.002	0.997	0.000
D28.9 Female genital organ, unspecified	0.002	0.997	0.000
D28.7 Other specified female genital organs	0.002	0.997	0.000
D28.2 Uterine tubes and ligaments	0.002	0.997	0.000
D28.1 Vagina	0.002	0.997	0.000
M47.80 Other spondylosis (Multiple sites in spine)	0.000	0.998	0.002
S82.41 Fracture of fibula alone (open)	0.002	0.998	0.000
S82.01 Fracture of patella (open)	0.002	0.998	0.000
S82.00 Fracture of patella (closed)	0.002	0.998	0.000
S82.71 Multiple fractures of lower leg (open)	0.002	0.998	0.000
S82.70 Multiple fractures of lower leg (closed)	0.002	0.998	0.000
S82.91 Fracture of lower leg, part unspecified (open)	0.002	0.998	0.000
S82.90 Fracture of lower leg, part unspecified (closed)	0.002	0.998	0.000
D11.9 Major salivary gland, unspecified	0.002	0.998	0.000
D11.7 Other major salivary glands	0.002	0.998	0.000
D11.0 Parotid gland	0.002	0.998	0.000
S80-S89 Injuries to the knee and lower leg	0.002	0.998	0.000
S82.86 Maisonneuve's fracture	0.002	0.998	0.000
S82.81 Fractures of other parts of lower leg (open)	0.002	0.998	0.000
D14.4 Respiratory system, unspecified	0.002	0.998	0.000
D14.3 Bronchus and lung	0.002	0.998	0.000
D14.2 Trachea	0.002	0.998	0.000
D14.1 Larynx	0.002	0.998	0.000
D14.0 Middle ear, nasal cavity and accessory sinuses	0.002	0.998	0.000
D15.9 Intrathoracic organ, unspecified	0.002	0.998	0.000
D15.7 Other specified intrathoracic organs	0.002	0.998	0.000
D15.2 Mediastinum	0.002	0.998	0.000
D15.1 Heart	0.002	0.998	0.000
D15.0 Thymus	0.002	0.998	0.000
D16.9 Bone and articular cartilage, unspecified	0.002	0.998	0.000
D16.8 Pelvic bones, sacrum and coccyx	0.002	0.998	0.000
D16.7 Ribs, sternum and clavicle	0.002	0.998	0.000
D16.6 Vertebral column	0.002	0.998	0.000
D16.5 Lower jaw bone	0.002	0.998	0.000
D16.4 Bones of skull and face	0.002	0.998	0.000
D16.3 Short bones of lower limb	0.002	0.998	0.000
D16.2 Long bones of lower limb	0.002	0.998	0.000
D16.1 Short bones of upper limb	0.002	0.998	0.000
D16.0 Scapula and long bones of upper limb	0.002	0.998	0.000
D19.9 Mesothelial tissue, unspecified	0.002	0.998	0.000
D19.7 Mesothelial tissue of other sites	0.002	0.998	0.000
D19.1 Mesothelial tissue of peritoneum	0.002	0.998	0.000
D19.0 Mesothelial tissue of pleura	0.002	0.998	0.000
D20.1 Peritoneum	0.002	0.998	0.000
D20.0 Retroperitoneum	0.002	0.998	0.000
D29.9 Male genital organ, unspecified	0.002	0.998	0.000
D29.7 Other male genital organs	0.002	0.998	0.000
D29.4 Scrotum	0.002	0.998	0.000
D29.3 Epididymis	0.002	0.998	0.000
D29.2 Testis	0.002	0.998	0.000
D29.1 Prostate	0.002	0.998	0.000
D29.0 Penis	0.002	0.998	0.000
D30.9 Urinary organ, unspecified	0.002	0.998	0.000
D30.7 Other urinary organs	0.002	0.998	0.000
D30.4 Urethra	0.002	0.998	0.000
D30.3 Bladder	0.002	0.998	0.000
D30.2 Ureter	0.002	0.998	0.000
D30.1 Renal pelvis	0.002	0.998	0.000
D30.0 Kidney	0.002	0.998	0.000
D31.9 Eye, unspecified	0.002	0.998	0.000
D31.6 Orbit, unspecified	0.002	0.998	0.000
D31.5 Lachrymal gland and duct	0.002	0.998	0.000
D31.4 Ciliary body	0.002	0.998	0.000
D31.3 Choroid	0.002	0.998	0.000
D31.2 Retina	0.002	0.998	0.000
D31.1 Cornea	0.002	0.998	0.000
D31.0 Conjunctiva	0.002	0.998	0.000
Y44.2 Anticoagulants	0.002	0.998	0.000
D21.1 Connective and other soft tissue of upper limb, including shoulder	0.002	0.998	0.000
D23.5 Skin of trunk	0.002	0.998	0.000
Chapter XX External causes of morbidity and mortality	0.002	0.998	0.000
H72.9 Perforation of tympanic membrane, unspecified	0.002	0.998	0.000
K82.4 Cholesterolosis of gallbladder	0.002	0.998	0.000
D34 Benign neoplasm of thyroid gland	0.002	0.998	0.000
S82.80 Fractures of other parts of lower leg (closed)	0.002	0.998	0.000
S82.21 Fracture of shaft of tibia (open)	0.002	0.998	0.000
D10.9 Pharynx, unspecified	0.002	0.998	0.000
D10.7 Hypopharynx	0.002	0.998	0.000
D10.6 Nasopharynx	0.002	0.998	0.000
D10.5 Other parts of oropharynx	0.002	0.998	0.000
D10.4 Tonsil	0.002	0.998	0.000
D10.2 Floor of mouth	0.002	0.998	0.000
D10.1 Tongue	0.002	0.998	0.000
D10.0 Lip	0.002	0.998	0.000
D18.1 Lymphangioma, any site	0.002	0.998	0.000
D32.9 Meninges, unspecified	0.002	0.998	0.000
D32.1 Spinal meninges	0.002	0.998	0.000
W13 Fall from, out of or through building or structure	0.002	0.998	0.000
D22.2 Melanocytic naevi of ear and external auricular canal	0.002	0.998	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
W10 Fall on and from stairs and steps	0.002	0.998	0.000
D23.6 Skin of upper limb, including shoulder	0.002	0.998	0.000
D35 Benign neoplasm of other and unspecified endocrine glands	0.002	0.998	0.000
D37.0 Lip, oral cavity and pharynx	0.002	0.998	0.000
D45 Polycythaemia vera	0.002	0.998	0.000
M47.89 Other spondylosis (Site unspecified)	0.000	0.998	0.002
M47.88 Other spondylosis (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M47.85 Other spondylosis (Thoracolumbar region)	0.000	0.998	0.002
M47.84 Other spondylosis (Thoracic region)	0.000	0.998	0.002
M47.83 Other spondylosis (Cervicothoracic region)	0.000	0.998	0.002
M47.81 Other spondylosis (Occipito-atlanto-axial region)	0.000	0.998	0.002
V10-V19 Pedal cyclist injured in transport accident	0.002	0.998	0.000
H42 Glaucoma in diseases classified elsewhere	0.002	0.998	0.000
D13.9 Ill-defined sites within the digestive system	0.002	0.998	0.000
D13.7 Endocrine pancreas	0.002	0.998	0.000
D13.6 Pancreas	0.002	0.998	0.000
D13.5 Extrahepatic bile ducts	0.002	0.998	0.000
D13.4 Liver	0.002	0.998	0.000
D13.3 Other and unspecified parts of small intestine	0.002	0.998	0.000
D13.2 Duodenum	0.002	0.998	0.000
D13.0 Oesophagus	0.002	0.998	0.000
W07 Fall involving chair	0.002	0.998	0.000
D10.3 Other and unspecified parts of mouth	0.002	0.998	0.000
D22.6 Melanocytic naevi of upper limb, including shoulder	0.002	0.998	0.000
W13.9 Unspecified place	0.002	0.998	0.000
W19 Unspecified fall	0.002	0.998	0.000
D22.1 Melanocytic naevi of eyelid, including canthus	0.002	0.998	0.000
D32.0 Cerebral meninges	0.002	0.998	0.000
W10.8 Other specified place	0.002	0.998	0.000
D18.0 Haemangioma, any site	0.002	0.998	0.000
D22.7 Melanocytic naevi of lower limb, including hip	0.002	0.998	0.000
D37.9 Digestive organ, unspecified	0.002	0.998	0.000
D37.7 Other digestive organs	0.002	0.998	0.000
D37.6 Liver, gallbladder and bile ducts	0.002	0.998	0.000
D37.3 Appendix	0.002	0.998	0.000
D37.2 Small intestine	0.002	0.998	0.000
D37.1 Stomach	0.002	0.998	0.000
S82.20 Fracture of shaft of tibia (closed)	0.002	0.998	0.000
V18 Pedal cyclist injured in noncollision transport accident	0.002	0.998	0.000
X50-X57 Overexertion, travel and privation	0.002	0.998	0.000
D22.9 Melanocytic naevi, unspecified	0.002	0.998	0.000
D22.4 Melanocytic naevi of scalp and neck	0.002	0.998	0.000
D22.0 Melanocytic naevi of lip	0.002	0.998	0.000
M47.1 Other spondylosis with myelopathy	0.000	0.998	0.002
M47.0 Anterior spinal and vertebral artery compression syndromes	0.000	0.998	0.002
Z45.8 Adjustment and management of other implanted devices	0.002	0.998	0.000
W18 Other fall on same level	0.002	0.998	0.000
W17 Other fall from one level to another	0.002	0.998	0.000
W16 Diving or jumping into water causing injury other than drowning or submersion	0.002	0.998	0.000
W15 Fall from cliff	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations